Jan. 14, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system ...

In this article, we are going to take a look at where Adaptive Biotechnologies Corporation (NASDAQ:ADPT) stands against the other stocks that are skyrocketing now. The market has started to favor ...

Investors in Adaptive Biotechnologies Corp (Symbol: ADPT) saw new options become available this week, for the October 17th expiration. One of the key data points that goes into the price an option ...

ROBERT HERSHBERG, a director at $ADPT, sold 53,000 shares of the company on 03-12-2025 for an estimated $402,270. We received data on the trade from a recent SEC ...

Shares of NASDAQ ADPT opened at $7.84 on Monday. Adaptive Biotechnologies has a one year low of $2.28 and a one year high of $8.33. The firm has a market capitalization of $1.16 billion ...

Adaptive Biotechnologies (ADPT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report)’s stock price fell 6.1% on Thursday after an insider sold shares in the company.The company traded as low as $7.46 and last traded ...